from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2456c/-

LFCtreatmentdescriptionclass of inhibitor

-0.580

Amikacinug/mL Amikacintranslation

-0.867

Cap5-10ug/mL Capreomycintranslation

-0.531

Rox10-50 ug/mL Roxithromycintranslation

-0.991

SM2-5 ug/mL Streptomycintranslation

-0.925

Tet5-10 ug/mL Tetracyclinetranslation

-0.186

Rif0.2-5ug/mL Rifampicintranscription

-0.203

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.020

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.151

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.374

CPZ10-50 ug/mL Chlorpromazinerespiration

0.598

Clofazimine10-13 ug/mL Clofaziminerespiration

0.612

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.122

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.557

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.306

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.364

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.173

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.423

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.382

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.300

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.961

KCN5-20 ug/mL Potassium cyaniderespiration

0.030

NaN30.2-2 mM Sodium aziderespiration

-0.895

Nigericin50 uM Nigericinrespiration

0.101

TRC10-150 ug/mL Triclosanrespiration

1.208

TRZ10-25 ug/mL Thioridazinerespiration

-0.531

Valinomycin0.5-10 uM Valinomycinrespiration

-1.088

ZnSO42 mM ZnSO4respiration

-0.156

menadione6-10 ug/mL Menadionerespiration

0.524

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.463

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.250

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.203

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.716

NRP_1Non-replicating persistence stage 1dosRassociated

-0.424

Amp0.2mg/mL AmpicillincellWall

-0.010

Cephalexin20-100 ug/mL CephalexincellWall

-0.212

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.785

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.396

EMB10-20 ug/mL EthambutolcellWall

-0.572

Eta12-40 ug/mL EthionamidecellWall

-0.644

INH0.2-0.4 ug/mL IsoniazidcellWall

0.452

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.270

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.917

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.311

BZA0.12 mg/mL BenzamidearomaticAmides

-0.021

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.416

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.132

H2O24 mM hydrogen peroxideDNAdamaging

0.232

Levo10 ug/mL LevofloxacinDNAdamaging

0.481

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.843

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.503

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.424

UVUV-irradiationDNAdamaging

0.446

ARP41-4 ug/mL Antitubercular compound ARP4?

0.757

Antimycin12.5-50 ug/mL Antimycin A?

-0.293

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.593

PA_110-50 ug/mL Antitubercular compound PA-1?

0.668

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.081

PA8240.2-2 ug/mL PA-824?

-0.299

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.264

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.201

Verapamil50 uM Verapamil?

-0.306

mercaptoethanol2 mM 2-Mercaptoethanol?

0.352

methoxatin10-20 ug/mL Methoxatin?